Sara Ricardo

Has grant

Associate Professor

Instituto Universitário de Ciências da Saúde

Portugal

Research Interests

Explore related searches

Professors in Portugal Professors in Immunology Immunology professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sara Ricardo is an Associate Professor at the Instituto Universitário de Ciências da Saúde in Portugal. Her research focuses on drug resistance in cancer, with recent articles exploring the role of compounds from mushrooms in cancer treatment, as well as the molecular mechanisms underlying the aggressiveness of ovarian cancer. Additionally, she investigates the effects of various treatments on tumor growth and therapeutic resistance in pancreatic and high-grade serous carcinoma.

Recent Grants

Grant: Close

COVIDT

Open Date: 2020-06-01

Close Date: 2020-12-01

Grant: Close

RESEARCH COVID-19 ao projeto 510 - Impact of covid-19 on the treatment of cancer patients [ 613686665 ]

Open Date: 2020-06-01

Close Date: 2021-03-01

Grant: Close

Blocking MUC16-mesothelin interaction to abrogate peritoneal metastization of ovarian cancer (PTDC/MEC-ONC/29503/2017)

Open Date: 2018-07-01

Close Date: 2021-07-01

Grant: Close

HOPE - Improving ovarian cancer patients survival

Open Date: 2018-04-01

Close Date: 2022-03-01

Grant: Close

Advancing cancer research: from basic knowledgment to application II (CANCER)

Open Date: 2017-05-01

Close Date: 2019-05-01

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (17)

Ricardo Silvestre

University of Minho

PORTUGAL

Sara Ricardo

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (21)

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer

In Silico Identification of Six Mushroom-Derived Sterol and Triterpenoid Compounds as Potential P-Glycoprotein Modulators in Multidrug Resistance

P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma

Antioxidant treatment attenuates age-related placenta GLUT-1 and PLIN-2 downregulation

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options

Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression

The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review

Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures

Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines

Author Correction: A method for Boolean analysis of protein interactions at a molecular level

Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins

Editorial: New molecular approaches to improve gynecological cancer management

Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action

Immune Tumor Microenvironment in Ovarian Cancer Ascites

Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma

A method for Boolean analysis of protein interactions at a molecular level

InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays

Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer

Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

Collaborators (17)

Ricardo Silvestre

Ana C. Moreira

Fernando Schmitt

Rute Oliveira

Alan Richardson

Raquel Almeida

Hassan Bousbaa

Ola Söderberg

Maria Salomé Gomes

Patrícia Silva

Johan Heldin

Leonor David

Josiana Adelaide Vaz

Mariana Nunes

Ricardo Jorge Dinis-Oliveira

Albina Dolores Resende

Lucília Saraiva

Make your next move.